PT3353175T - Sais e formas sólidas de um antibiótico monobactâmico - Google Patents

Sais e formas sólidas de um antibiótico monobactâmico

Info

Publication number
PT3353175T
PT3353175T PT168480994T PT16848099T PT3353175T PT 3353175 T PT3353175 T PT 3353175T PT 168480994 T PT168480994 T PT 168480994T PT 16848099 T PT16848099 T PT 16848099T PT 3353175 T PT3353175 T PT 3353175T
Authority
PT
Portugal
Prior art keywords
salts
solid forms
monobactam antibiotic
monobactam
antibiotic
Prior art date
Application number
PT168480994T
Other languages
English (en)
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PT3353175T publication Critical patent/PT3353175T/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/427Thiazoles not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PT168480994T 2015-09-23 2016-09-20 Sais e formas sólidas de um antibiótico monobactâmico PT3353175T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201562222430P 2015-09-23 2015-09-23

Publications (1)

Publication Number Publication Date
PT3353175T true PT3353175T (pt) 2020-09-10

Family

ID=58385723

Family Applications (1)

Application Number Title Priority Date Filing Date
PT168480994T PT3353175T (pt) 2015-09-23 2016-09-20 Sais e formas sólidas de um antibiótico monobactâmico

Country Status (25)

Country Link
US (1) US10919887B2 (pt)
EP (1) EP3353175B1 (pt)
JP (1) JP6837480B2 (pt)
KR (1) KR20180054816A (pt)
CN (1) CN108137573B (pt)
AU (1) AU2016327264B2 (pt)
CA (1) CA2999794C (pt)
CL (2) CL2018000745A1 (pt)
CY (1) CY1123509T1 (pt)
DK (1) DK3353175T3 (pt)
EA (2) EA202092620A1 (pt)
ES (1) ES2817537T3 (pt)
HK (1) HK1257271A1 (pt)
HR (1) HRP20201423T1 (pt)
HU (1) HUE050849T2 (pt)
IL (1) IL258254B (pt)
LT (1) LT3353175T (pt)
MA (1) MA42946B1 (pt)
MX (1) MX2018003592A (pt)
PH (1) PH12018500653A1 (pt)
PT (1) PT3353175T (pt)
RS (1) RS60805B1 (pt)
RU (1) RU2754180C2 (pt)
SI (1) SI3353175T1 (pt)
WO (1) WO2017050218A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019026004A2 (en) * 2017-08-02 2019-02-07 Novartis Ag CHEMICAL PROCESS FOR THE PREPARATION OF ANTIBIOTIC MONOBACTAM AND ITS INTERMEDIATES
US11760866B2 (en) * 2017-08-16 2023-09-19 Lg Chem, Ltd. White pigment comprising ZIF-based powder, polymer resin film and method for changing color of medium using white pigment
US20200360349A1 (en) * 2017-11-10 2020-11-19 Novartis Ag Administration of monobactam for the treatment of urinary tract infection
CN111511737B (zh) * 2018-01-29 2022-10-18 南京明德新药研发有限公司 用于治疗细菌感染的单环β-内酰胺化合物
JP7179185B2 (ja) * 2018-12-18 2022-11-28 メッドシャイン ディスカバリー インコーポレイテッド 医薬の製造おける単環式β-ラクタム化合物の使用
WO2021098840A1 (zh) * 2019-11-22 2021-05-27 南京明德新药研发有限公司 磺酰脲环取代的单环β-内酰胺类抗生素
EP4079305A4 (en) 2019-12-19 2024-01-10 Shenzhen Optimum Biological Technology Co., Ltd APPLICATION OF A COMPOUND IN THE PREPARATION OF DRUG
CN113754651B (zh) 2020-06-02 2023-04-18 中国医学科学院医药生物技术研究所 一种β-内酰胺化合物、其用途及其制备方法
WO2022027439A1 (en) * 2020-08-06 2022-02-10 Ningxia Academy Of Agriculture And Forestry Sciences β-LACTAM COMPOUNDS, THEIR PREPARATION AND USE AS ANTIBACTERIAL AGENTS
WO2022185240A1 (en) 2021-03-04 2022-09-09 Bp Asset Vi, Inc. Formulation of a monobactam antibiotic
WO2022185241A1 (en) 2021-03-04 2022-09-09 Bp Asset Vi, Inc. Process for manufacturing a monobactam antibiotic
CN115304594B (zh) * 2022-10-12 2023-02-14 苏州二叶制药有限公司 磺酰脲环取代的化合物的盐型及其晶型

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ205240A (en) 1980-02-07 1984-07-31 Squibb & Sons Inc Sulphonamide derivatives,being starting materials for producing beta-lactams
US4775670A (en) 1980-09-29 1988-10-04 E. R. Squibb & Sons, Inc. 2-oxo-1-azetidinesulfonic acid salts
EP0048953B1 (en) 1980-09-29 1988-03-09 E.R. Squibb & Sons, Inc. Beta-lactam antibiotics
WO1982001873A1 (en) 1980-12-05 1982-06-10 Takeda Chemical Industries Ltd 1-sulfo-2-oxoazetidine derivatives and process for their preparation
US4782147A (en) 1980-12-05 1988-11-01 Takeda Chemical Industries, Ltd. 1-sulfo-2-oxoazetidine derivatives and their production
CA1262128A (en) 1981-08-27 1989-10-03 Christian N. Hubschwerlen .beta.-lactams
IL67451A (en) 1981-12-25 1987-10-20 Takeda Chemical Industries Ltd 4-cyano-2-azetidinones and production thereof and process for the preparation of 4-carbamoyl-2-azetidinones using them
AU564150B2 (en) * 1982-04-30 1987-08-06 Takeda Chemical Industries Ltd. 1-sulfo-2-azetidinone derivatives
HU189290B (en) 1982-05-31 1986-06-30 Banyu Pharmaceutical Co Ltd,Jp Process for preparing new 2-oxo-1-azetidine-sulphonic acid derivatives and pharmaceutically acceptable salts thereof, further pharmaceutical compositions containing such derivatives as active substances
DE3377061D1 (en) 1982-06-03 1988-07-21 Hoffmann La Roche Process for the preparation of 1-sulfo-2-oxoazetidine derivatives
JPS6153282A (ja) 1984-08-22 1986-03-17 Banyu Pharmaceut Co Ltd 単環β−ラクタム誘導体
JPS6153283A (ja) 1984-08-24 1986-03-17 Banyu Pharmaceut Co Ltd 2−オキソ−1−アゼチジンスルホン酸誘導体
US4610824A (en) 1984-10-09 1986-09-09 E. R. Squibb & Sons, Inc. Hydrazide derivatives of monocyclic beta-lactam antibiotics
US5112968A (en) 1989-07-28 1992-05-12 E. R. Squibb & Sons, Inc. Monobactam hydrazide derivatives
PE20120010A1 (es) 2008-10-31 2012-02-07 Shionogi & Co Cefalosporinas que tienen un grupo catecol
CN102325769A (zh) * 2008-12-19 2012-01-18 美国辉瑞有限公司 单卡波姆
SG190007A1 (en) 2010-11-29 2013-06-28 Pfizer Monobactams
UY34585A (es) * 2012-01-24 2013-09-02 Aicuris Gmbh & Co Kg Compuestos b-lactámicos sustituidos con amidina, su preparación y uso
CN103044416A (zh) 2012-12-17 2013-04-17 浙江华方药业有限责任公司 一种卡芦莫南钠的合成方法
US20160326157A1 (en) 2014-01-06 2016-11-10 President And Fellows Of Harvard College Monobactams and methods of their synthesis and use
WO2015148379A1 (en) 2014-03-24 2015-10-01 Novartis Ag Monobactam organic compounds for the treatment of bacterial infections

Also Published As

Publication number Publication date
CA2999794A1 (en) 2017-03-30
RU2018114480A3 (pt) 2020-06-09
EA037569B1 (ru) 2021-04-15
MA42946A (fr) 2018-08-01
SI3353175T1 (sl) 2020-11-30
EP3353175A4 (en) 2019-06-26
KR20180054816A (ko) 2018-05-24
EP3353175B1 (en) 2020-08-12
MA42946B1 (fr) 2020-10-28
JP6837480B2 (ja) 2021-03-03
HRP20201423T1 (hr) 2020-12-11
CN108137573A (zh) 2018-06-08
AU2016327264B2 (en) 2019-06-27
US20180273522A1 (en) 2018-09-27
EA202092620A1 (ru) 2021-06-30
EA201890771A1 (ru) 2018-09-28
CY1123509T1 (el) 2022-03-24
RS60805B1 (sr) 2020-10-30
LT3353175T (lt) 2020-10-12
CN108137573B (zh) 2021-06-11
RU2754180C2 (ru) 2021-08-30
CL2019003324A1 (es) 2020-04-17
EP3353175A1 (en) 2018-08-01
RU2018114480A (ru) 2019-10-23
IL258254B (en) 2021-02-28
DK3353175T3 (da) 2020-09-14
PH12018500653A1 (en) 2018-10-01
WO2017050218A1 (en) 2017-03-30
AU2016327264A1 (en) 2018-05-10
HUE050849T2 (hu) 2021-01-28
IL258254A (en) 2018-05-31
CA2999794C (en) 2023-08-15
JP2018528241A (ja) 2018-09-27
ES2817537T3 (es) 2021-04-07
MX2018003592A (es) 2018-06-18
US10919887B2 (en) 2021-02-16
HK1257271A1 (zh) 2019-10-18
CL2018000745A1 (es) 2018-06-22
BR112018005805A2 (pt) 2018-10-16

Similar Documents

Publication Publication Date Title
HK1257271A1 (zh) 單環內酰胺抗生素的鹽和固體形式
EP3360043A4 (en) ASSESSING THE EFFECTIVENESS OF CYBER SECURITY TECHNOLOGIES
SG11201706729SA (en) Derivatives of sobetirome
HK1253049A1 (zh) 糖基相互作用化合物及其使用方法
IL257026A (en) Solid state forms of eluxadoline
GB201514756D0 (en) Compound and method of use
IL259796A (en) Aza-benzimidazole inhibitors of pad4
SI3845221T1 (sl) Trdne oblike sofosbuvirja
GB201521059D0 (en) Inhibitors of metallo-beta-lactamases
IL246979A0 (en) Crystalline forms of sofosbuvir
ZA201706282B (en) Solid forms of menaquinols
IL268048A (en) Preparation salts and compounds of 1-methyl-d-tryptophan
EP3107540A4 (en) Polymorphs of lomitapide and its salts
HK1250926A1 (zh) 抑制劑及其應用
RS60939B1 (sr) Čvrsti oblici soli nilotiniba
PL3297622T3 (pl) Kombinacje oksykodonu i n-acyloetanoloaminy palmitoiloetanoloaminy do zmniejszenia skutków ubocznych związanych z opioidami
SG11201708527RA (en) Manufacture of organopolysulfides and salts thereof
HUP1500506A2 (en) Salts of palbociclib
PT3160263T (pt) Composições para prevenção de infeções
GB201621771D0 (en) New salts of compounds and uses thereof
IL249332A0 (en) Crystalline forms of sofosbuvir
GB201519795D0 (en) Construction of surfaces
GB201505975D0 (en) Inhibitors and their uses
GB201505971D0 (en) Inhibitors and their uses
GB201418230D0 (en) Construction of surfaces